TGFB1 and neoplasm: Studies have shown that TGF-β could promote the infiltration of T regulatory cells and inhibit the function of effector T cells and natural killer cells, which induces immune suppression within the TME, thus causing tumor immune evasion and poor prognosis in the high-risk group (Batlle and Massagué, 2019).